These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35365728)

  • 1. Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis.
    Sheridan DA; Shawa IT; Thomas EL; Felmlee DJ; Bridge SH; Neely D; Cobbold JF; Holmes E; Bassendine MF; Taylor-Robinson SD
    Sci Rep; 2022 Apr; 12(1):5562. PubMed ID: 35365728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner.
    Clark PJ; Thompson AJ; Vock DM; Kratz LE; Tolun AA; Muir AJ; McHutchison JG; Subramanian M; Millington DM; Kelley RI; Patel K
    Hepatology; 2012 Jul; 56(1):49-56. PubMed ID: 22318926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin.
    Younossi ZM; Stepanova M; Estep M; Negro F; Clark PJ; Hunt S; Song Q; Paulson M; Stamm LM; Brainard DM; Subramanian GM; McHutchison JG; Patel K
    J Hepatol; 2016 Jan; 64(1):29-36. PubMed ID: 26341824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a.
    Hofer H; Bankl HC; Wrba F; Steindl-Munda P; Peck-Radosavljevic M; Osterreicher C; Mueller C; Gangl A; Ferenci P
    Am J Gastroenterol; 2002 Nov; 97(11):2880-5. PubMed ID: 12425563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Serum Lipids with Hepatic Steatosis, Stage of Liver Fibrosis and Viral Load in Chronic Hepatitis C.
    Valkov I; Ivanova R; Alexiev A; Antonov K; Mateva L
    J Clin Diagn Res; 2017 Aug; 11(8):OC15-OC20. PubMed ID: 28969178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism.
    Bridge SH; Sheridan DA; Felmlee DJ; Crossey MM; Fenwick FI; Lanyon CV; Dubuc G; Seidah NG; Davignon J; Thomas HC; Taylor-Robinson SD; Toms GL; Neely RD; Bassendine MF
    J Hepatol; 2015 Apr; 62(4):763-70. PubMed ID: 25463543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipid pattern in chronic hepatitis C: histological and virological correlations.
    Siagris D; Christofidou M; Theocharis GJ; Pagoni N; Papadimitriou C; Lekkou A; Thomopoulos K; Starakis I; Tsamandas AC; Labropoulou-Karatza C
    J Viral Hepat; 2006 Jan; 13(1):56-61. PubMed ID: 16364083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication.
    Abomughaid M; Tay ESE; Pickford R; Malladi C; Read SA; Coorssen JR; Gloss BS; George J; Douglas MW
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.
    Patra T; Sasaki R; Meyer K; Ray RB; Ray R
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study.
    Spaziante M; Taliani G; Marchetti G; Tavelli A; Lichtner M; Cingolani A; Cicalini S; Biliotti E; Girardi E; Antinori A; Puoti M; d'Arminio Monforte A; Cozzi-Lepri A
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro.
    Rojas Á; del Campo JA; Maraver M; Aparcero R; García-Valdecasas M; Diago M; Carmona I; Andrade RJ; Solà R; Romero-Gómez M
    J Viral Hepat; 2014 Jan; 21(1):19-24. PubMed ID: 24188401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipid profile and hepatic steatosis of adult beta-thalassaemia patients with chronic HCV infection.
    Siagris D; Kouraklis-Symeonidis A; Christofidou M; Lekkou A; Papadimitriou C; Arvaniti V; Thomopoulos K; Tsamandas A; Zoumbos N; Labropoulou-Karatza C
    Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):345-50. PubMed ID: 15716660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic alterations and hepatitis C: From bench to bedside.
    Chang ML
    World J Gastroenterol; 2016 Jan; 22(4):1461-76. PubMed ID: 26819514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C.
    AlQaraawi AM; Sanai FM; Al-Husseini H; Albenmousa A; AlSheikh A; Ahmed LR; Hersi A; Al-Otaibi MM; Syed M; Ali SM; Al-hamoudi W; Alswat KA; Abdo AA
    Dig Dis Sci; 2011 Apr; 56(4):1222-8. PubMed ID: 20931285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of lipid metabolic alterations in hepatitis C patients after viral clearance: Incomplete restoration with accelerated ω-oxidation.
    Chang SW; Cheng ML; Shiao MS; Yeh CT; Wang CH; Fan CM; Chiu CT; Chang ML
    J Clin Lipidol; 2018; 12(3):756-766. PubMed ID: 29574072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of pan-genotypic and genotype-specific amino acid alterations in chronic hepatitis C after viral clearance: transition at the crossroad of metabolism and immunity.
    Chang ML; Cheng ML; Chang SW; Tang HY; Chiu CT; Yeh CT; Shiao MS
    Amino Acids; 2017 Feb; 49(2):291-302. PubMed ID: 27830380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolism.
    Harada R; Kimura M; Sato Y; Taniguchi T; Tomonari T; Tanaka T; Tanaka H; Muguruma N; Shinomiya H; Honda H; Imoto I; Sogabe M; Okahisa T; Takayama T
    BMC Gastroenterol; 2018 Jan; 18(1):24. PubMed ID: 29382324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
    Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM
    Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy.
    González-Aldaco K; Torres-Reyes LA; Ojeda-Granados C; José-Ábrego A; Fierro NA; Román S
    Ann Hepatol; 2018 Oct; 17(6):908-919. PubMed ID: 30600305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-acting antiviral agents against hepatitis C virus and lipid metabolism.
    Kanda T; Moriyama M
    World J Gastroenterol; 2017 Aug; 23(31):5645-5649. PubMed ID: 28883690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.